![](/img/cover-not-exists.png)
An Adaptive, Dose-Finding, Seamless Phase 2/3 Study of a Long-Acting Glucagon-like Peptide-1 Analog (Dulaglutide): Trial Design and Baseline Characteristics
Geiger, M. J., Skrivanek, Z., Gaydos, B., Chien, J., Berry, S., Berry, D., Anderson, J. H.Volume:
6
Language:
english
Journal:
Journal of Diabetes Science and Technology
DOI:
10.1177/193229681200600610
Date:
November, 2012
File:
PDF, 658 KB
english, 2012